USA Today (2/10, Alltucker) reported, “Medicare will begin collecting penalties in 2025 from pharmaceutical companies that raise prices on prescription drugs faster than the rate of inflation, the Centers for Medicare and Medicaid Service said” last week. Also, “on April 1, Medicare enrollees on Part B drugs, typically administered by a doctor, might benefit from more moderate coinsurance charges, CMS officials said.” CMS “released draft guidance Thursday on the rebate program and will solicit feedback from the public over the next 30 days before finalizing details.”
Related Links:
— “Medicare targets drug companies that raise prices above rate of inflation “Ken Alltucker, USA TODAY, February 10, 2023